In the BioHarmony Drug Report Database
Triprolidine
Actidil (triprolidine) is a small molecule pharmaceutical. Triprolidine was first approved as Actidil on 1983-07-01. It is used to treat allergic conjunctivitis, atopic dermatitis, and rhinitis in the USA. The pharmaceutical is active against histamine H1 receptor.
Trade Name
|
Actidil |
|---|---|
Common Name
|
triprolidine |
ChEMBL ID
|
CHEMBL855 |
Indication
|
allergic conjunctivitis, atopic dermatitis, rhinitis |
Drug Class
|
Image (chem structure or protein)